WHY IT'S IMPORTANT. Cycle Pharma's $8 per share proposal is an 80% premium to Vanda's last closing price, valuing the company at $488 million. The potential offer follows a 4.5% fall in Vanda's ...

Vanda Pharmaceuticals Inc. VNDA shares are trading lower after Future Pak withdrew its proposal to purchase the company. “Consistent with the position indicated in its June 13, 2024 letter to ...

The end of the trading week likely can't come fast enough for Vanda Pharmaceuticals (NASDAQ: VNDA). The commercial-stage biotech's stock took an almost 6% hit on Thursday, following some ...

England-based rare disease drug maker Cycle Pharma revealed an $8-per-share offer for Vanda, representing a total buyout offer of $466 million.

Early this month, Cycle Pharma got involved with a buyout offer of $8 per share, or $466 million in total.At the time, Vanda said it would "carefully review and evaluate the indication of interest ...

Vanda Pharma surges on $8 a share takeover offer from Cycle Pharma (update) Jun. 06, 2024 9:38 AM ET Vanda Pharmaceuticals Inc. (VNDA) Stock By: Joshua Fineman, SA News Editor 7 Comments.

Cycle Pharmaceuticals reaffirmed its proposal to acquire all of the issued and outstanding shares of Vanda Pharmaceuticals for an all-cash consideration of $8.00 per Vanda share. Cycle said it is ...

Vanda Pharmaceuticals (NASDAQ:VNDA) jumped 11% after Cycle Pharmaceuticals reaffirmed its $8/share all cash offer for the company. "Cycle is making its renewed proposal public for the benefit of ...

Explore Vanda Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VNDA.

Vanda Pharmaceuticals Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia. PR Newswire. WASHINGTON, March 31, 2025.

What happened Shares of Vanda Pharmaceuticals (NASDAQ: VNDA) fell more than 19% today after the company announced it was pursuing legal action.

Vanda Pharmaceuticals (VNDA) provided an update on the tradipitant development program. Gastroparesis is a serious digestive disorder of the stomach. Vanda began studying tradipitant almost 10 ...